Robert L. Ferrara - 20 May 2025 Form 4 Insider Report for Phio Pharmaceuticals Corp. (PHIO)

Role
Director
Signature
/s/ Robert L. Ferrara
Issuer symbol
PHIO
Transactions as of
20 May 2025
Net transactions value
+$4,550
Form type
4
Filing time
21 May 2025, 16:13:14 UTC
Previous filing
12 Sep 2024
Next filing
11 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Ferrara Robert L Director C/O PHIO PHARMACEUTICALS CORP., 11 APEX DR., SUITE 300A, PMB 2006, MARLBOROUGH /s/ Robert L. Ferrara 21 May 2025 0001792987

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PHIO Common stock, $0.0001 par value Purchase $4,550 +2,500 +23% $1.82 13,166 20 May 2025 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at $1.82. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the transactions.
F2 Includes shares of common stock underlying unvested restricted stock units.
F3 The number of reported securities has been adjusted to reflect prior reverse stock splits.